Colorectal cancer screening with fecal occult blood test: A 22-year cohort study

被引:14
|
作者
Jin, Peng [1 ,2 ]
Wu, Zi-Tao [1 ]
Li, Shi-Rong [1 ]
Li, Shu-Jun [1 ]
Wang, Ji-Heng [1 ]
Wang, Zhi-Hong [1 ]
Lu, Jian-Guo [1 ]
Cui, Xin-Juan [1 ]
Han, Ying [1 ]
Rao, Jianyu [3 ,4 ]
Sheng, Jian-Qiu [1 ]
机构
[1] Beijing Mil Gen Hosp, Dept Gastroenterol, Beijing 100700, Peoples R China
[2] Third Mil Med Univ, Chongqing 400038, Peoples R China
[3] Univ Calif Los Angeles, Dept Pathol & Lab Med, David Geffen Sch Med, Los Angeles, CA 90015 USA
[4] Univ Calif Los Angeles, Dept Epidemiol, Sch Publ Hlth, Los Angeles, CA 90015 USA
关键词
colorectal cancer; screening; fecal occult blood test; POPULATION; MULTICENTER;
D O I
10.3892/ol.2013.1402
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of the present study was to investigate the efficacy of colorectal cancer (CRC) screening with a three-tier fecal occult blood test (FOBT) in the Chinese population. The study was performed between 1987 and 2008 at the Beijing Military General Hospital, in a cohort of army service males and females aged >50 years. Between 1987 and 2005, a three-tier screening program, comprising guaiac-based FOBTs (gFOBTs), followed by immunochemical FOBTs for positive guaiac test samples and then colonoscopy for positive immunochemical test subjects, was performed annually. The cohort was followed up until 2008. The cohort included 5,104 subjects, of which, 3,863 subjects participated in screening (screening group) and 1,241 did not (non-screening group). The two groups did not differ in age, gender or other major risk factors for colon cancer. Overall, 36 CRCs occurred in the screening group and 21 in the non-screening group. Compared with the non-screening group, the relative risk for the incidence and mortality of CRC was 0.51 [95% confidence interval (CI), 0.30-0.87] and 0.36 (95% CI, 0.18-0.71), respectively, in the screening group. The general sensitivity of this three-tier FOBT was 80.6% (95% CI, 65.3-91.1). Thus, annual screening using the three-tier FOBT program may reduce the CRC incidence and mortality rate.
引用
收藏
页码:576 / 582
页数:7
相关论文
共 50 条
  • [21] Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
    Yang, Cuiping
    Wu, Wei
    Yang, Yanping
    Yang, Xiaojin
    Sun, Jing
    Zhang, Weiyu
    Liu, Kun
    Ying, Haifeng
    Jiang, Songyao
    Yu, Xiaojun
    Shi, Yiqing
    Zhou, Yufen
    Zhu, Shiyan
    Xu, Ying
    Ding, Yanfei
    Xie, Ling
    Cai, Boer
    Xin, Xiaorong
    Chen, Ping
    Zhao, Ren
    Wu, Yunlin
    ONCOLOGY LETTERS, 2020, 20 (02) : 1193 - 1200
  • [22] Screening for colorectal cancer using the fecal occult blood test: An actuarial assessment of the impact of a population-based screening program in Canada
    Villeneuve, PJ
    Coombs, A
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (04) : 715 - 723
  • [23] The public prefers fecal occult blood test over colonoscopy for colorectal cancer screening
    Almog, Ronit
    Ezra, Gili
    Lavi, Idit
    Rennert, Gad
    Hagoel, Lea
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2008, 17 (05) : 430 - 437
  • [24] Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands
    Maaike J Denters
    Marije Deutekom
    Paul Fockens
    Patrick MM Bossuyt
    Evelien Dekker
    BMC Gastroenterology, 9
  • [25] Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening
    Maru Kim
    Hyung-Jin Kim
    In Kyu Lee
    Seong-Taek Oh
    Kyungja Han
    European Surgery, 2017, 49 : 127 - 131
  • [26] Fecal occult blood test/fecal carcinoembriogenic antigen dual rapid test as a useful tool for colorectal cancer screening
    Kim, Maru
    Kim, Hyung-Jin
    Lee, In Kyu
    Oh, Seong-Taek
    Han, Kyungja
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2017, 49 (03): : 127 - 131
  • [27] Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá, G
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (06): : A234 - A235
  • [28] Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá, G
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (05): : 234 - 235
  • [29] Population-based colorectal cancer screening: comparison of two fecal occult blood test
    Zubero, Miren B.
    Arana-Arri, Eunate
    Pijoan, Jose I.
    Portillo, Isabel
    Idigoras, Isabel
    Lopez-Urrutia, Antonio
    Samper, Ana
    Uranga, Begona
    Rodriguez, Carmen
    Bujanda, Luis
    FRONTIERS IN PHARMACOLOGY, 2014, 4
  • [30] Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program
    C Pornet
    B Denis
    P Perrin
    I Gendre
    G Launoy
    British Journal of Cancer, 2014, 111 : 2152 - 2155